Vanderbilt University: Kidney Diseases trials
The registry lists 11 Kidney Diseases studies with Vanderbilt University as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 2 7No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis PatientsCompletedNCT00420290Not applicableResults posted
- Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid TrialCompletedNCT01992926Not applicable
- Targeting Social Determinants to Improve Chronic Kidney Disease CareCompletedNCT01604577Not applicable
- Oxidative Stress in Chronic Kidney Disease: Diet and ExerciseCompletedNCT01150851Not applicable
- Reduced Calorie Diet Intervention in Kidney Transplant RecipientsCompletedNCT00994838Phase 2
- Vitamin D, Insulin Resistance and Inflammation in ESRDCompletedNCT00656032Phase 2
- Omega-3 Fatty Acid Administration in Dialysis PatientsCompletedNCT00655525Phase 2
- Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney DiseaseTerminatedNCT00581269Phase 2
- Metabolic Effects of Thiazolidinediones in Chronic Kidney DiseaseTerminatedNCT00368017Phase 2
- Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)CompletedNCT00308971Phase 2
- Prevention and Treatment of Hemodialysis Vascular Access MalfunctionWithdrawnNCT00179192Phase 2